€23.55
0.88% today
L&S, Jul 02, 10:00 pm CET
ISIN
DE000A288904
Symbol
COP
Index

CompuGroup Medical Target price 2024 - Analyst rating & recommendation

CompuGroup Medical Classifications & Recommendation:

Buy
60%
Hold
40%

CompuGroup Medical Target price

Target price €42.80
Course €23.50
Price potential
Number of estimates 10
10 Analysts have issued a price target CompuGroup Medical 2025 . The average CompuGroup Medical target price is €42.80. This is higher than the current share price. The highest price target is
€64.00 172.34%
register free of charge
, the lowest is .
A rating was issued by 10 analysts: 6 Analysts recommend CompuGroup Medical to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the CompuGroup Medical share has an average upside potential 2025 of . Most analysts recommend the CompuGroup Medical share at Purchase.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Forecast
Turnover Billion € 1.19 1.24
5.13% 4.18%
EBITDA margin 22.81% 22.17%
7.86% 2.83%
Net margin 3.86% 7.29%
40.63% 88.63%

10 Analysts have issued a sales forecast CompuGroup Medical 2024 . The average CompuGroup Medical sales estimate is

€1.2b
Unlock
. This is
4.73% higher
Unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
€1.3b 6.14%
Unlock
, the lowest is
€1.2b 3.49%
Unlock
.

This results in the following potential growth figures:

Sales forecast

2023 €1.2b 5.13%
2024
€1.2b 4.18%
Unlock
2025
€1.3b 4.56%
Unlock
2026
€1.4b 5.31%
Unlock
2027
€1.4b 4.15%
Unlock

10 Analysts have issued an CompuGroup Medical EBITDA forecast 2024. The average CompuGroup Medical EBITDA estimate is

€274m
Unlock
. This is
2.62% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€304m 13.72%
Unlock
, the lowest is
€239m 10.59%
Unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 €271m 13.39%
2024
€274m 1.24%
Unlock
2025
€299m 8.99%
Unlock
2026
€318m 6.22%
Unlock
2027
€338m 6.59%
Unlock
2028
€306m 9.60%
Unlock

EBITDA margin

2023 22.81% 7.86%
2024
22.17% 2.83%
Unlock
2025
23.11% 4.24%
Unlock
2026
23.31% 0.87%
Unlock
2027
23.85% 2.32%
Unlock

9 CompuGroup Medical Analysts have issued a net profit forecast 2024. The average CompuGroup Medical net profit estimate is

€90.2m
Unlock
. This is
80.19% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€122m 143.88%
Unlock
, the lowest is
€56.9m 13.53%
Unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 €45.9m 37.59%
2024
€90.2m 96.58%
Unlock
2025
€106m 17.72%
Unlock
2026
€119m 11.70%
Unlock
2027
€182m 53.33%
Unlock

Net margin

2023 3.86% 40.63%
2024
7.29% 88.63%
Unlock
2025
8.21% 12.62%
Unlock
2026
8.71% 6.09%
Unlock
2027
12.82% 47.19%
Unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Forecast
Earnings per share 0.88 1.73
37.59% 96.59%
P/E ratio 13.73
EV/Sales 1.52

9 Analysts have issued a CompuGroup Medical forecast for earnings per share. The average CompuGroup Medical <a href=/blog/eps>EPS is

€1.73
Unlock
. This is
80.21% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
€2.34 143.75%
Unlock
, the lowest is
€1.09 13.54%
Unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 €0.88 37.59%
2024
€1.73 96.59%
Unlock
2025
€2.04 17.92%
Unlock
2026
€2.27 11.27%
Unlock
2027
€3.49 53.74%
Unlock

P/E ratio

Current 24.79 26.94%
2024
13.73 44.61%
Unlock
2025
11.67 15.00%
Unlock
2026
10.45 10.45%
Unlock
2027
6.81 34.83%
Unlock

Based on analysts' sales estimates for 2024, the CompuGroup Medical share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 1.60 37.50%
2024
1.52 4.74%
Unlock
2025
1.46 4.36%
Unlock
2026
1.38 5.05%
Unlock
2027
1.33 3.98%
Unlock

P/S ratio

Current 1.04 48.35%
2024
0.99 4.52%
Unlock
2025
0.95 4.36%
Unlock
2026
0.90 5.05%
Unlock
2027
0.87 3.98%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today